Efficacy of motivating short interventions for smokers in primary care (COSMOS trial): study protocol for a cluster-RCT.
Alcohol Drinking
Data Interpretation, Statistical
Double-Blind Method
Exercise
Feeding Behavior
Female
General Practitioners
Humans
Male
Motivation
Outcome Assessment, Health Care
Primary Health Care
Randomized Controlled Trials as Topic
Research Design
Sample Size
Smokers
/ psychology
Smoking Cessation
/ methods
Counselling
Health behaviour
Health promotion
Motivational interviewing
Patient-centredness
Primary care
Shared decision-making
Smoking cessation
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
25 Jan 2019
25 Jan 2019
Historique:
received:
08
02
2018
accepted:
23
11
2018
entrez:
27
1
2019
pubmed:
27
1
2019
medline:
29
5
2019
Statut:
epublish
Résumé
Tobacco abuse is a frequent issue in general practitioners' (GPs') offices, with doctors playing a key role in promoting smoking cessation to their patients. However, not all smokers are ready and willing to give up smoking. Thus, a GP focusing on smoking cessation alone might waste the opportunity to improve his patient's health by supporting a change in another harmful behaviour pattern. The aim of this study is to determine whether multi-thematic coaching will lead to higher overall health benefits without resulting in a reduced rate of successful smoking cessations, compared with a monothematic smoking cessation approach. The study is designed as a two-armed, double-blinded, cluster-randomised trial. GPs will be randomly assigned to the intervention or control group. In the intervention group, GPs will undergo training in patient-centred coaching, shared decision-making and motivational interviewing. The control group will be trained in a state-of-the-art smoking cessation algorithm. GPs will approach adult cigarette-smoking patients and advise those included according to the GP's group affiliation. The primary outcome is the between-group difference in the proportion of participants who achieve a beneficial change in at least one of seven different health-related behavioural dimensions, 12 months post baseline. Secondary outcomes include smoking cessation rates and the patients' self-perceived smoking-related motivation, self-efficacy and planning behaviour. Additionally, covariates describing both GPs and patients will be collected before the start of the intervention, and process outcome measures in compliance with the RE-AIM (Reach Effectiveness Adoption Implementation Maintenance) framework will be recorded during the ongoing study. Tobacco consumption is still highly prevalent in the general population and often goes hand in hand with other behaviour patterns with adverse health effects. This study will add to the literature regarding effective strategies available to GPs to address unhealthy behaviour among their smoking patients beyond mere smoking cessation counselling. The study will also establish a basis for decisions about further promotion and dissemination of the coaching under study. ISRCTN, ISRCTN38129107 . Registered on 2 October 2017.
Sections du résumé
BACKGROUND
BACKGROUND
Tobacco abuse is a frequent issue in general practitioners' (GPs') offices, with doctors playing a key role in promoting smoking cessation to their patients. However, not all smokers are ready and willing to give up smoking. Thus, a GP focusing on smoking cessation alone might waste the opportunity to improve his patient's health by supporting a change in another harmful behaviour pattern. The aim of this study is to determine whether multi-thematic coaching will lead to higher overall health benefits without resulting in a reduced rate of successful smoking cessations, compared with a monothematic smoking cessation approach.
METHODS
METHODS
The study is designed as a two-armed, double-blinded, cluster-randomised trial. GPs will be randomly assigned to the intervention or control group. In the intervention group, GPs will undergo training in patient-centred coaching, shared decision-making and motivational interviewing. The control group will be trained in a state-of-the-art smoking cessation algorithm. GPs will approach adult cigarette-smoking patients and advise those included according to the GP's group affiliation. The primary outcome is the between-group difference in the proportion of participants who achieve a beneficial change in at least one of seven different health-related behavioural dimensions, 12 months post baseline. Secondary outcomes include smoking cessation rates and the patients' self-perceived smoking-related motivation, self-efficacy and planning behaviour. Additionally, covariates describing both GPs and patients will be collected before the start of the intervention, and process outcome measures in compliance with the RE-AIM (Reach Effectiveness Adoption Implementation Maintenance) framework will be recorded during the ongoing study.
DISCUSSION
CONCLUSIONS
Tobacco consumption is still highly prevalent in the general population and often goes hand in hand with other behaviour patterns with adverse health effects. This study will add to the literature regarding effective strategies available to GPs to address unhealthy behaviour among their smoking patients beyond mere smoking cessation counselling. The study will also establish a basis for decisions about further promotion and dissemination of the coaching under study.
TRIAL REGISTRATION
BACKGROUND
ISRCTN, ISRCTN38129107 . Registered on 2 October 2017.
Identifiants
pubmed: 30683155
doi: 10.1186/s13063-018-3071-z
pii: 10.1186/s13063-018-3071-z
pmc: PMC6347802
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
81Subventions
Organisme : Tobacco-prevention fund (TPF), Swiss Federal Office of Public Health (FOPH)
ID : 17.003152
Références
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
J Gen Intern Med. 2003 Dec;18(12):1023-7
pubmed: 14687261
Med Sci Sports Exerc. 2004 Jul;36(7):1181-6
pubmed: 15235322
Addiction. 2005 Mar;100(3):299-303
pubmed: 15733243
Contemp Clin Trials. 2005 Apr;26(2):260-7
pubmed: 15837446
Alcohol Alcohol. 2005 Sep-Oct;40(5):461-8
pubmed: 15939708
JAMA. 2005 Sep 28;294(12):1505-10
pubmed: 16189363
Clin Trials. 2004;1(3):297-305
pubmed: 16279255
Int J Obes (Lond). 2006 Mar;30(3):391-9
pubmed: 16302013
Tob Control. 2006 Dec;15(6):472-80
pubmed: 17130377
Psychosom Med. 2006 Nov-Dec;68(6):816-23
pubmed: 17132834
Prev Med. 2007 Apr;44(4):335-40
pubmed: 17350085
Respir Care. 2008 Sep;53(9):1217-22
pubmed: 18807274
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD000484
pubmed: 18843609
BMC Med Res Methodol. 2008 Oct 09;8:65
pubmed: 18844993
Curr Med Res Opin. 2010 Apr;26(4):991-1002
pubmed: 20201624
Addiction. 2011 Mar;106 Suppl 1:11-9
pubmed: 21324017
Lancet. 2011 Oct 1;378(9798):1244-53
pubmed: 21846575
N Engl J Med. 2011 Nov 24;365(21):1969-79
pubmed: 22082239
Gastroenterol Hepatol (N Y). 2012 Apr;8(4):241-8
pubmed: 22723755
BMC Med Res Methodol. 2013 Jan 23;13:9
pubmed: 23343209
Cochrane Database Syst Rev. 2013 May 31;(5):CD000165
pubmed: 23728631
BMC Fam Pract. 2013 Jul 17;14:100
pubmed: 23865509
PLoS One. 2015 Mar 20;10(3):e0121993
pubmed: 25794148
Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1145-53
pubmed: 25931456
Obesity (Silver Spring). 2016 Apr;24(4):812-9
pubmed: 26935138
Ann Intern Med. 2016 May 3;164(9):585-92
pubmed: 26975007
BMC Psychiatry. 2016 May 23;16:159
pubmed: 27216151
BMC Med Res Methodol. 2018 Oct 16;18(1):108
pubmed: 30326827
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699